~~<i id='DF895A4D93'><strike id='DF895A4D93'><tt id='DF895A4D93'><pre id='DF895A4D93'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：Wikipedia 2025-10-02 19:59:33 Page View：718

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare eyes cuts to doctors, raises to outpatient clinics in 2024
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

focus

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Meta looks to target Twitter with a rival app called Threads

Theannouncementofthesocialmediaapp'Threads'isdisplayedinApple'sUSAppStoreseenonthescreenofasmartphon

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

Europe sees delivery challenges ahead on Alzheimer's therapies

VialsandpackagingforLeqembi,anewAlzheimer'smedicationapprovedintheU.S.,butnotyetinEurope.Illustratio